Bookmark and Share
opioid receptor, kappa 1 [Homo sapiens] [gi:119607129] - Target BioActivity Data
Filters: All Data » Active      
Filter selected
BioActivity Outcomes:
Active(128)
 
 
BioAssay Types:
Screening(72)
 
 
Confirmatory(34)
 
 
BioActivity Types:
IC50(34)
 
 
Substance Types:
Chemical(128)
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 5    Data Row: 128   Total Pages: 7   Display: Page     
Sort: [Click the result table header to sort]
#StructureSubstanceCompoundActivityBioAssayLinks
OutcomeTypeValue [μM]
1
[SID144087319]
[CID60156214]
IC50 0.00916Late-stage results from the probe development effort to identify antagonists of OPRK1: fluorescence-based cell-based dose response assay, Set 2. [AID652084, Type: confirmatory]
View
2
[SID144087319]
[CID60156214]
IC50 0.0164Late-stage results from the probe development effort to identify antagonists of OPRK1: fluorescence-based cell-based dose response assay [AID652032, Type: confirmatory]
View
3
[SID144087324]
[CID60156231]
IC50 0.075Late-stage results from the probe development effort to identify antagonists of OPRK1: fluorescence-based cell-based dose response assay [AID652032, Type: confirmatory]
View
4
[SID144087321]
[CID60156232]
IC50 0.079Late-stage results from the probe development effort to identify antagonists of OPRK1: fluorescence-based cell-based dose response assay [AID652032, Type: confirmatory]
View
5
[SID144087313]
[CID60156237]
IC50 0.11Late-stage results from the probe development effort to identify antagonists of OPRK1: fluorescence-based cell-based dose response assay [AID652032, Type: confirmatory]
View
6
[SID144087314]
[CID60156217]
IC50 0.12Late-stage results from the probe development effort to identify antagonists of OPRK1: fluorescence-based cell-based dose response assay [AID652032, Type: confirmatory]
View
7
[SID144087303]
[CID60156211]
IC50 0.133Late-stage results from the probe development effort to identify antagonists of OPRK1: fluorescence-based cell-based dose response assay [AID652032, Type: confirmatory]
View
8
[SID144087323]
[CID60156212]
IC50 0.159Late-stage results from the probe development effort to identify antagonists of OPRK1: fluorescence-based cell-based dose response assay [AID652032, Type: confirmatory]
View
9
[SID144087309]
[CID60156221]
IC50 0.185Late-stage results from the probe development effort to identify antagonists of OPRK1: fluorescence-based cell-based dose response assay [AID652032, Type: confirmatory]
View
10
[SID144087298]
[CID60156210]
IC50 0.231Late-stage results from the probe development effort to identify antagonists of OPRK1: fluorescence-based cell-based dose response assay [AID652032, Type: confirmatory]
View
11
[SID144087315]
[CID60156235]
IC50 0.267Late-stage results from the probe development effort to identify antagonists of OPRK1: fluorescence-based cell-based dose response assay [AID652032, Type: confirmatory]
View
12
[SID144087322]
[CID60156234]
IC50 0.398Late-stage results from the probe development effort to identify antagonists of OPRK1: fluorescence-based cell-based dose response assay [AID652032, Type: confirmatory]
View
13
[SID160844010]
[CID2796048]
IC50 0.41Late-stage fluorescence-based cell-based dose response assay for antagonists of kappa opioid receptor 1 (OPRK1) [AID652077, Type: confirmatory]
View
14
[SID144087310]
[CID60156240]
IC50 0.536Late-stage results from the probe development effort to identify antagonists of OPRK1: fluorescence-based cell-based dose response assay [AID652032, Type: confirmatory]
View
15
[SID144087304]
[CID60156205]
IC50 0.579Late-stage results from the probe development effort to identify antagonists of OPRK1: fluorescence-based cell-based dose response assay [AID652032, Type: confirmatory]
View
16
[SID144087308]
[CID60156238]
IC50 0.621Late-stage results from the probe development effort to identify antagonists of OPRK1: fluorescence-based cell-based dose response assay [AID652032, Type: confirmatory]
View
17
[SID144087326]
[CID60156213]
IC50 0.628Late-stage results from the probe development effort to identify antagonists of OPRK1: fluorescence-based cell-based dose response assay [AID652032, Type: confirmatory]
View
18
[SID144087306]
[CID60156206]
IC50 0.652Late-stage results from the probe development effort to identify antagonists of OPRK1: fluorescence-based cell-based dose response assay [AID652032, Type: confirmatory]
View
19
[SID160844001]
[CID2809477]
IC50 1.05Late-stage fluorescence-based cell-based dose response assay for antagonists of kappa opioid receptor 1 (OPRK1) [AID652077, Type: confirmatory]
View
20
[SID160844008]
[CID2741001]
IC50 1.58Late-stage fluorescence-based cell-based dose response assay for antagonists of kappa opioid receptor 1 (OPRK1) [AID652077, Type: confirmatory]
View